Laura V. Doyle

Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.

H Y Min, Laura V. Doyle, C R Vitt et al. · PubMed · 1996 · 246 citations

Medicine, Oncology, Pharmacology +11

Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis.

Nitin K. Damle, Laura V. Doyle, J R Bender et al. · The Journal of Immunology · 1987 · 217 citations · Full text

Life Sciences, Immunology, Oncology +12

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

Steven E. Kauder, Tracy C. Kuo, Ons Harrabi et al. · PLoS ONE · 2018 · 171 citations · Full text

Medicine, Immunology, Oncology +17

Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

Nitin K. Damle, Laura V. Doyle, E C Bradley · The Journal of Immunology · 1986 · 165 citations · Full text

Life Sciences, Cell Biology, Immunology +9

Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines.

Abla A. Creasey, Laura V. Doyle, M Reynolds et al. · PubMed · 1987 · 127 citations

Medicine, Cancer Biology, Oncology +10